Claripharm
Private Company
Total funding raised: $1.8M
Overview
Claripharm is a private, commercial-stage company operating in the consumer health and feminine care segment of the broader drug delivery sector. It has developed a portfolio of branded, sustainable menstrual hygiene products (Claripad) and supplements, targeting consumers seeking safer, reusable alternatives to conventional products. The company employs a direct-to-consumer e-commerce model with a focus on French sourcing and production. Its strategy includes educational initiatives, such as a 'first period' kit for adolescents, and B2B partnerships to provide products in workplaces.
Technology Platform
Proprietary design and material science for reusable feminine hygiene products, utilizing organic cotton, PUL (Polyurethane Laminate) membranes, and sizing/absorption customization.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Claripharm competes in the sustainable feminine hygiene segment against global D2C brands (e.g., Thinx, DivaCup, Dame), larger CPG companies launching eco-lines, and numerous local European startups. Its primary differentiation is its strong French sourcing narrative and bundled educational kits, competing on brand ethos and local appeal rather than technological superiority.